HBsAg loss is enough to discontinue long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B patients in real practice?
Fasano, M., Ciarallo, M., Niro, G., Fontana, R., Cozzolongo, R., Maci, A., Carraturo, I., Miglietta, A., Angarano, G., Santantonio, T.Volume:
47
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2015.01.029
Date:
February, 2015
File:
PDF, 56 KB
english, 2015